Newbridge Financial Services Group, Inc. Surface Oncology, Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	BUY	$2.65 - $5.08 $1,073 - $2,057	405 New	405 $1,000
Q3 2021 Oct 27, 2021	SELL	$5.16 - $7.98 $5,160 - $7,980	-1,000 Closed	0 $0
Q2 2021 Sep 07, 2021	BUY	$6.45 - $9.09 $1,935 - $2,727	300 Added 42.86%	1,000 $7,000
Q1 2021 Sep 07, 2021	BUY	$7.25 - $13.82 $5,075 - $9,674	700 New	700 $5,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.